{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,13]],"date-time":"2026-10-13T15:30:03Z","timestamp":1791905403910,"version":"4.3.4"},"reference-count":45,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2007,8,1]],"date-time":"2007-08-01T00:00:00Z","timestamp":1185926400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Current Science Inc"],"published-print":{"date-parts":[[2007,8]]},"DOI":"10.1007\/s11916-007-0205-5","type":"journal-article","created":{"date-parts":[[2007,8,21]],"date-time":"2007-08-21T23:49:25Z","timestamp":1187740165000},"page":"283-289","source":"Crossref","is-referenced-by-count":27,"title":["Neuraxial pain relief for intractable cancer pain"],"prefix":"10.1007","volume":"11","author":[{"given":"Paul A.","family":"Sloan","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2007,8,23]]},"reference":[{"key":"205_CR1","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1007\/s00520-004-0731-1","volume":"13","author":"P.A. Sloan","year":"2005","unstructured":"Sloan PA, Slatkin NE, Ahdieh H: Effectiveness and safety of oral extended-release oxymorphone for the treatment of cancer pain: a pilot study. Support Care Cancer 2005, 13:57\u201365.","journal-title":"Support Care Cancer"},{"key":"205_CR2","first-page":"125","volume":"115","author":"R. Melzack","year":"1976","unstructured":"Melzack R, Ofiesh JG, Mount BM: The Brompton mixture: effects on pain in cancer patients. Can Med Assoc J 1976, 115:125\u2013129.","journal-title":"Can Med Assoc J"},{"key":"205_CR3","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/S0885-3924(05)80006-5","volume":"5","author":"S.A. Schug","year":"1990","unstructured":"Schug SA, Zech D, Dorr U: Cancer pain management according to WHO analgesic guidelines. J Pain Symptom Manage 1990, 5:27\u201332.","journal-title":"J Pain Symptom Manage"},{"key":"205_CR4","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1300\/J011v14n02_03","volume":"14","author":"P.A. Sloan","year":"1999","unstructured":"Sloan PA, Melzack R: Long-term patterns of morphine dosage and pain intensity among cancer patients. Hosp J 1999, 14:35\u201347.","journal-title":"Hosp J"},{"key":"205_CR5","first-page":"1","volume":"2","author":"P.A. Sloan","year":"2004","unstructured":"Sloan PA: The evolving role of interventional pain management in oncology. J Support Oncol 2004, 2:1\u201311.","journal-title":"J Support Oncol"},{"key":"205_CR6","doi-asserted-by":"crossref","first-page":"338","DOI":"10.1016\/S0885-3924(01)00250-0","volume":"21","author":"S. Mercandante","year":"2001","unstructured":"Mercandante S, Portenoy RK: Opioid poorly responsive cancer pain, part 3: clinical strategies to improve opioid responsiveness. J Pain Symptom Manage 2001, 21:338\u2013354.","journal-title":"J Pain Symptom Manage"},{"key":"205_CR7","doi-asserted-by":"crossref","first-page":"1108","DOI":"10.1034\/j.1399-6576.2001.450910.x","volume":"45","author":"B.A. Meyerson","year":"2001","unstructured":"Meyerson BA: Neurosurgical approaches to pain treatment. Acta Anaesthesiol Scand 2001, 45:1108\u20131113.","journal-title":"Acta Anaesthesiol Scand"},{"key":"205_CR8","doi-asserted-by":"crossref","first-page":"651","DOI":"10.1053\/bean.2002.0253","volume":"16","author":"D. Kedlaya","year":"2002","unstructured":"Kedlaya D, Reynolds L, Waldman S: Epidural and intrathecal analgesia for cancer pain. Best Prac Res Clin Anaesth 2002, 16:651\u2013665.","journal-title":"Best Prac Res Clin Anaesth"},{"key":"205_CR9","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S0304-3959(98)00118-3","volume":"79","author":"S. Mercadante","year":"1999","unstructured":"Mercadante S: Problems of long-term spinal opioid treatment in advanced cancer patients. Pain 1999, 79:1\u201313.","journal-title":"Pain"},{"key":"205_CR10","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1126\/science.150.3699.971","volume":"150","author":"R. Melzack","year":"1965","unstructured":"Melzack R, Wall PD: Pain mechanisms: a new theory. Science 1965, 150:171\u2013179.","journal-title":"Science"},{"key":"205_CR11","doi-asserted-by":"crossref","first-page":"1011","DOI":"10.1126\/science.179.4077.1011","volume":"179","author":"C.B. Pert","year":"1973","unstructured":"Pert CB, Snyder SH: Opiate receptor: demonstration in nervous tissue. Science 1973, 179:1011\u20131014.","journal-title":"Science"},{"key":"205_CR12","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1097\/00000542-197902000-00013","volume":"50","author":"J.K. Wang","year":"1979","unstructured":"Wang JK, Nauss LA, Thomas JE: Pain relief by intrathecally applied morphine in man. Anesthesiology 1979, 50:149\u2013151.","journal-title":"Anesthesiology"},{"key":"205_CR13","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1016\/0885-3924(94)90131-7","volume":"9","author":"S. Mercadante","year":"1994","unstructured":"Mercadante S: Intrathecal morphine and bupivacaine in advanced cancer pain patients implanted at home. J Pain Symptom Manage 1994, 9:201\u2013207.","journal-title":"J Pain Symptom Manage"},{"key":"205_CR14","first-page":"399","volume":"3","author":"L. Stearns","year":"2005","unstructured":"Stearns L, Boortz-Marx R, Du Pen S, et al.: Intrathecal drug delivery for the management of cancer pain: a multidisciplinary consensus of best clinical practices. J Support Oncol 2005, 3:399\u2013408.","journal-title":"J Support Oncol"},{"key":"205_CR15","first-page":"S37","volume":"13","author":"E.S. Krames","year":"1999","unstructured":"Krames ES: Practical issues when using neuraxial infusion. Oncology 1999, 13:S37\u2013S44.","journal-title":"Oncology"},{"key":"205_CR16","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1097\/00115550-199924031-00074","volume":"24","author":"S. Mercadante","year":"1999","unstructured":"Mercadante S: Neuraxial techniques for cancer pain: an opinion about unresolved therapeutic dilemmas. Reg Anesth Pain Med 1999, 24:74\u201383.","journal-title":"Reg Anesth Pain Med"},{"key":"205_CR17","doi-asserted-by":"crossref","first-page":"S14","DOI":"10.1016\/S0885-3924(97)00167-X","volume":"14","author":"J.A. Paice","year":"1997","unstructured":"Paice JA, Winkelmuller W, Burchief K, et al.: Clinical realities and economic considerations: efficacy of intrathecal pain therapy. J Pain Symptom Manage 1997, 14:S14\u2013S26.","journal-title":"J Pain Symptom Manage"},{"key":"205_CR18","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1016\/0304-3959(92)90183-C","volume":"49","author":"K.A. Follett","year":"1992","unstructured":"Follett KA, Hitchon PW, Piper J, et al.: Response of intractable pain to continuous intrathecal morphine: a retrospective study. Pain 1992, 49:21\u201325.","journal-title":"Pain"},{"key":"205_CR19","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1097\/00006123-199801000-00009","volume":"42","author":"B. Sallerin-Caute","year":"1998","unstructured":"Sallerin-Caute B, Lazorthes Y, Deguine O, et al.: Does intrathecal morphine in the treatment of cancer pain induce the development of tolerance? Neurosurgery 1998, 42:44\u201349.","journal-title":"Neurosurgery"},{"key":"205_CR20","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1016\/0885-3924(94)00071-R","volume":"10","author":"H. Samuelsson","year":"1995","unstructured":"Samuelsson H, Malber F, Eriksson M, Hedner T: Outcomes of epidural morphine treatment in cancer pain: nine years of clinical experience. J Pain Symptom Manage 1995, 10:105\u2013112.","journal-title":"J Pain Symptom Manage"},{"key":"205_CR21","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1097\/00002508-199803000-00004","volume":"14","author":"P. Nitescu","year":"1998","unstructured":"Nitescu P, Dahm P, Appelgren L, Curelaru I: Continuous infusion of opioid and bupivacaine by externalized intrathecal catheters in long-term treatment of refractory nonmalignant pain. Clin J Pain 1998, 14:17\u201328.","journal-title":"Clin J Pain"},{"key":"205_CR22","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1016\/0304-3959(92)90234-3","volume":"49","author":"S.L. Pen Du","year":"1992","unstructured":"Du Pen SL, Kharash ED, Williams A, et al.: Chronic epidural bupivacaine-opioid infusion in intractable cancer pain. Pain 1992, 49:293\u2013300.","journal-title":"Pain"},{"key":"205_CR23","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1097\/00002508-199909000-00002","volume":"15","author":"R.T. Dongen van","year":"1999","unstructured":"van Dongen RT, Crul BJ, van Egmond J: Intrathecal coadministration of bupivacaine diminishes morphine dose progression during long-term intrathecal infusion in cancer patients. Clin J Pain 1999, 15:166\u2013172.","journal-title":"Clin J Pain"},{"key":"205_CR24","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1213\/01.ANE.0000067403.15926.BD","volume":"97","author":"S. Mercadante","year":"2003","unstructured":"Mercadante S, Villari P, Ferrera P, Arcuri E: Local anesthetic switching for intrathecal tachyphylaxis in cancer patients with pain. Anesth Analg 2003, 97:187\u2013189.","journal-title":"Anesth Analg"},{"key":"205_CR25","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1016\/0304-3959(94)00209-W","volume":"61","author":"J.C. Eisenach","year":"1995","unstructured":"Eisenach JC, Du Pen S, Dubois M, et al.: Epidural clonidine analgesia for intractable cancer pain. Pain 1995, 61:391\u2013399.","journal-title":"Pain"},{"key":"205_CR26","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1007\/BF03011718","volume":"43","author":"C.Y. Yang","year":"1996","unstructured":"Yang CY, Wong CS, Chang JY, Ho ST: Intrathecal ketamine reduces morphine requirements in patients with terminal cancer pain. Can J Anesth 1996, 43:379\u2013383.","journal-title":"Can J Anesth"},{"key":"205_CR27","doi-asserted-by":"crossref","first-page":"674","DOI":"10.1213\/00000539-200209000-00033","volume":"95","author":"S.M. Walker","year":"2002","unstructured":"Walker SM, Goudas LC, Cousins MJ, Carr DB: Combination spinal analgesic chemotherapy: a systematic review. Anesth Analg 2002, 95:674\u2013715.","journal-title":"Anesth Analg"},{"key":"205_CR28","doi-asserted-by":"crossref","first-page":"813","DOI":"10.1097\/00000542-200610000-00028","volume":"105","author":"J.H. Vranken","year":"2006","unstructured":"Vranken JH, Troost D, de Hann P, et al.: Severe toxic damage to the rabbit spinal cord after intrathecal administration of preservative-free S(+)-ketamine. Anesthesiology 2006, 105:813\u2013818.","journal-title":"Anesthesiology"},{"key":"205_CR29","doi-asserted-by":"crossref","first-page":"875","DOI":"10.1517\/13543784.13.7.875","volume":"13","author":"S.A. Doggrell","year":"2004","unstructured":"Doggrell SA: Intrathecal ziconotide for refractory pain. Expert Opin Investig Drugs 2004, 13:875\u2013877.","journal-title":"Expert Opin Investig Drugs"},{"key":"205_CR30","doi-asserted-by":"crossref","first-page":"295","DOI":"10.5055\/jom.2006.0044","volume":"2","author":"P.A. Sloan","year":"2006","unstructured":"Sloan PA, Hamann SR: Ultra low-dose opioid antagonists to enhance opioid analgesia. J Opioid Manage 2006, 2:295\u2013304.","journal-title":"J Opioid Manage"},{"key":"205_CR31","first-page":"73","volume":"1","author":"T.J. Smith","year":"2003","unstructured":"Smith TJ, Coyne PJ: How to use implantable intrathecal drug delivery systems for refractory cancer pain. J Support Oncol 2003, 1:73\u201376.","journal-title":"J Support Oncol"},{"key":"205_CR32","doi-asserted-by":"crossref","first-page":"254","DOI":"10.1007\/s11916-006-0029-8","volume":"10","author":"S.E. Brogan","year":"2006","unstructured":"Brogan SE: Intrathecal therapy for the management of cancer pain. Curr Pain Headache Rep 2006, 10:254\u2013259.","journal-title":"Curr Pain Headache Rep"},{"key":"205_CR33","doi-asserted-by":"crossref","first-page":"368","DOI":"10.1016\/0885-3924(91)90028-3","volume":"6","author":"M.D. Bedder","year":"1991","unstructured":"Bedder MD, Burchiel K, Larson A: Cost analysis of two implantable narcotic delivery systems. J Pain Symptom Manage 1991, 6:368\u2013373.","journal-title":"J Pain Symptom Manage"},{"key":"205_CR34","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1053\/rapm.2003.50025","volume":"28","author":"K.R. Han","year":"2003","unstructured":"Han KR, Kim C, Park SK, Kim JS: Distance to the adult cervical epidural space. Reg Anesth Pain Med 2003, 28:95\u201397.","journal-title":"Reg Anesth Pain Med"},{"key":"205_CR35","doi-asserted-by":"crossref","first-page":"S37","DOI":"10.1016\/S0885-3924(00)00202-5","volume":"20","author":"G. Bennett","year":"2000","unstructured":"Bennett G, Burchiel K, Buchser E, et al.: Clinical guidelines for intraspinal infusion: report of an expert panel. J Pain Symptom Manage 2000, 20:S37\u2013S43.","journal-title":"J Pain Symptom Manage"},{"key":"205_CR36","doi-asserted-by":"crossref","first-page":"4040","DOI":"10.1200\/JCO.2002.02.118","volume":"20","author":"T.J. Smith","year":"2002","unstructured":"Smith TJ, Staats PS, Deer T, et al.: Randomized clinical trial of an implantable drug delivery system compared with comprehensive medical management for refractory cancer pain: impact on pain, drug-related toxicity, and survival. J Clin Oncol 2002, 20:4040\u20134049.","journal-title":"J Clin Oncol"},{"key":"205_CR37","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1097\/00002508-200203000-00009","volume":"18","author":"G. Cerda-Olmedo","year":"2002","unstructured":"Cerda-Olmedo G, De Andres J, Moliner S: Management of progressive pain in a patient with intramedullary chordoma of the spine. Clin J Pain 2002, 18:128\u2013131.","journal-title":"Clin J Pain"},{"key":"205_CR38","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1016\/S0304-3959(00)00263-3","volume":"87","author":"Y. Lazorthes","year":"2002","unstructured":"Lazorthes Y, Sagen J, Sallerin B, et al.: Human chromaffin cell graft into the CSF for cancer pain management: a prospective phase II clinical study. Pain 2002, 87:19\u201332.","journal-title":"Pain"},{"key":"205_CR39","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1097\/00002508-199503000-00006","volume":"11","author":"P. Nitescu","year":"1995","unstructured":"Nitescu P, Sjoberg M, Appelgren L, Curelaru I: Complications of intrathecal opioids and bupivacaine in the treatment of refractory cancer pain. Clin J Pain 1995, 11:45\u201362.","journal-title":"Clin J Pain"},{"key":"205_CR40","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1007\/BF03012609","volume":"46","author":"M. Basta","year":"1999","unstructured":"Basta M, Sloan PA: Epidural hematoma following epidural catheter placement in a patient with chronic renal failure. Can J Anesth 1999, 46:271\u2013274.","journal-title":"Can J Anesth"},{"key":"205_CR41","doi-asserted-by":"crossref","first-page":"470","DOI":"10.1097\/00115550-200309000-00019","volume":"28","author":"E.E. Ubogu","year":"2003","unstructured":"Ubogu EE, Lindenberg JR, Werz MA: Transverse myelitis associated with Acinetobacter baumanii intrathecal pump catheter-related infection. Reg Anesth Pain Med 2003, 28:470\u2013474.","journal-title":"Reg Anesth Pain Med"},{"key":"205_CR42","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1016\/S0304-3959(96)03240-X","volume":"69","author":"R.T. Dongen van","year":"1997","unstructured":"van Dongen RT, van Ee R, Crul BJ: Neurological impairment during long-term intrathecal infusion of bupivacaine in cancer patients: a sign of spinal cord compression. Pain 1997, 69:205\u2013209.","journal-title":"Pain"},{"key":"205_CR43","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1097\/00000542-200609000-00024","volume":"105","author":"J.W. Allen","year":"2006","unstructured":"Allen JW, Horais KA, Tozier NA, et al.: Time course and role of morphine dose and concentration in intrathecal granuloma formation in dogs. Anesthesiology 2006, 105:581\u2013589.","journal-title":"Anesthesiology"},{"key":"205_CR44","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1046\/j.1526-4637.2002.02055.x","volume":"3","author":"S. Hassenbusch","year":"2002","unstructured":"Hassenbusch S, Burchiel K, Coffey RJ, et al.: Management of intrathecal catheter-tip inflammatory masses: a consensus statement. Pain Med 2002, 3:313\u2013323.","journal-title":"Pain Med"},{"key":"205_CR45","first-page":"78","volume":"50","author":"R.J. Coffey","year":"2002","unstructured":"Coffey RJ, Burchiel K: Inflammatory mass lesions associated with intrathecal drug infusion catheters: report and observations on 41 patients. Neurosurgery 2002, 50:78\u201386.","journal-title":"Neurosurgery"}],"container-title":["Current Pain and Headache Reports"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11916-007-0205-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s11916-007-0205-5\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11916-007-0205-5","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,5,13]],"date-time":"2023-05-13T21:24:03Z","timestamp":1684013043000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s11916-007-0205-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2007,8]]},"references-count":45,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2007,8]]}},"alternative-id":["205"],"URL":"https:\/\/doi.org\/10.1007\/s11916-007-0205-5","relation":{},"ISSN":["1531-3433","1534-3081"],"issn-type":[{"value":"1531-3433","type":"print"},{"value":"1534-3081","type":"electronic"}],"subject":[],"published":{"date-parts":[[2007,8]]}}}